All In MedTech

Device Trial Radar · NCT04369885

Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD)

Assessing Adherence to Home Telemedicine in Individuals With COPD

Last checked: Nov 19, 2026Latest source record: Nov 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

Jul 1, 2020

Primary completion

May 24, 2021

Study completion May 24, 2021

Sponsor

Lead sponsor
University of North Carolina, Chapel HillAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Midmark Corporation; Monitored Therapeutics, Inc
First posted
Apr 30, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a single-site feasibility pilot study to determine if patients with COPD with an increased risk of exacerbation will use an in-home COPD telemonitoring system for three months that collects lung measures, pulse oximetry, and medication compliance.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • Go Home tablet with linked GoSpiro and 3230 Pulse OximeterDevice

    All participants will receive the intervention consisting of a home telemedicine tablet platform (GoHome) that will collect multiple spirometry tests each week (including both forced and slow spirometry measurements), pulse oximetry, and QoL Questionnaire responses. The platform will remind patients to take their medications remind patients to perform measurements, send patients helpful information, and execute a UNC clinic established COPD Action Plan.The backend of the platform is a remote server (Monitored Therapeutics CarePortal) that collects the data, send out alerts to the Principal Investigator and can track and trend the data for them.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Home Device Measurement Collection AdherenceTime frame: 3 months
  2. Percentage of Participants With Decrease in COPD Assessment Test (CAT) ScoreTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Meadowmont Marsico Lung Research Center

    Chapel Hill, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.